In addition, SP was responsible for the symptoms of tendinopathy with the upregulation of COX2. In conclusion, our results suggest that an abnormal increase in SP expression plays a crucial role in the development of tendinopathy and associated symptoms, suggesting its use as a possible future therapeutic target for potential treatments. This evidence concerns the gene PTGS2 and disease of the tendon.